Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish

7.8K Views

09:50 min

April 10th, 2020

DOI :

10.3791/60996-v

April 10th, 2020


Transkrypcja

Przeglądaj więcej filmów

Zebrafish Xenograft

Rozdziały w tym wideo

0:04

Introduction

0:54

Fluorescently Labeling Cells with DiI(1,1 -Dioctadecyl-3,3,3 ,3 -Tetramethylindocarbocyanine Perchlorate)

2:10

Microinjecting Zebrafish Larvae

4:37

Setting up Drug Screen with Xenografted Zebrafish

6:22

Imaging Xenografted Zebrafish and Quantifying Fluorescence

8:36

Results: Xenografted Tumor Area

9:22

Conclusion

Powiązane Filmy

article

09:53

Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies

12.0K Views

article

07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

13.5K Views

article

09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

13.8K Views

article

07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

6.8K Views

article

09:56

Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment

9.0K Views

article

10:03

Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells

8.5K Views

article

11:07

In Vivo Imaging and Quantitation of the Host Angiogenic Response in Zebrafish Tumor Xenografts

6.8K Views

article

08:42

Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines

9.6K Views

article

10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

7.1K Views

article

07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

4.6K Views

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone